Medicine and Dentistry
Programmed Cell Death
100%
Prognostic Factor
100%
PI3K/AKT Pathway
100%
Diffuse Large B-Cell Lymphoma
100%
Lymphoma Cell
33%
Hazard Ratio
33%
Overall Survival
33%
Progression Free Survival
33%
Antiapoptotic
16%
Disease
16%
Cell Death
16%
Transcription Factors
16%
Multivariate Analysis
16%
Treatment Response
16%
Immunology and Microbiology
B Cell
100%
Lymphoma Cell
33%
Progression Free Survival
33%
Overall Survival
33%
Cell Death
16%
Transcription Factors
16%
Pharmacology, Toxicology and Pharmaceutical Science
Diffuse Large B Cell Lymphoma
100%
Overall Survival
33%
Progression Free Survival
33%
Antiapoptotic
16%
Disease
16%
Transcription Factors
16%
Biochemistry, Genetics and Molecular Biology
B Cell
100%
Overall Survival
33%
Progression Free Survival
33%
Transcription Factors
16%
Multivariate Analysis
16%
Cell Death
16%
Keyphrases
ABT-263
33%
Immunochemotherapy
16%
Overall Survival Progression-free Survival
16%
Apoptosis Resistance
16%